Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Return on Capital Employed (2016 - 2018)

Armata Pharmaceuticals' Return on Capital Employed history spans 5 years, with the latest figure at 1.96% for Q3 2018.

  • For Q3 2018, Return on Capital Employed rose 54.0% year-over-year to 1.96%; the TTM value through Sep 2018 reached 1.96%, up 54.0%, while the annual FY2017 figure was 1.27%, N/A changed from the prior year.
  • Return on Capital Employed for Q3 2018 was 1.96% at Armata Pharmaceuticals, down from 0.82% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.3% in Q3 2015 and bottomed at 2.96% in Q2 2017.
  • The 5-year median for Return on Capital Employed is 0.53% (2016), against an average of 1.08%.
  • The largest annual shift saw Return on Capital Employed tumbled -197bps in 2017 before it soared 214bps in 2018.
  • A 5-year view of Return on Capital Employed shows it stood at 0.5% in 2014, then surged by 40bps to 0.3% in 2015, then plummeted by -375bps to 1.43% in 2016, then decreased by -8bps to 1.54% in 2017, then decreased by -27bps to 1.96% in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Return on Capital Employed are 1.96% (Q3 2018), 0.82% (Q2 2018), and 1.44% (Q1 2018).